Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Graeme Sutherland launches The Long Goodbye podcast
4+ hour ago (216+ words) A new podcast is launching to provide support and understanding for families affected by Alzheimer’s disease and dementia. Graeme Sutherland, a media influencer and content creator, is launching The Long Goodbye, a series inspired by his own family’s experience after…...
Kota medical student receives ACPs Researcher of the Year Award
3+ hour, 32+ min ago (14+ words) ...
Runners raise money for children with cancer on East Bay Bike Path
7+ hour, 50+ min ago (33+ words) Yahoo Hundreds of runners took to the East Bay Bike Path on Saturday for the Mark Palumbo Memorial University Orthopedics 5K....
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
8+ hour, 10+ min ago (848+ words) Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). In the primary endpoint analysis, Enhertu monotherapy significantly reduced…...
New palliative care unit for children to be set up in memory of Gourock campaigner
6+ hour, 17+ min ago (694+ words) A GROUND-BREAKING new unit to care for children with terminal illnesses is to be set up in the name of incredible Gourock campaigner Molly Cuddihy a year after her death. Molly's Suite is a palliative care hub to be created…...
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
6+ hour, 25+ min ago (338+ words) Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, South Korea (abstract #PL03.08). In the primary endpoint of PFS, Enhertu monotherapy…...
Holistic palliative care is in the conversations of dying well
9+ hour, 28+ min ago (1807+ words) Vandersman didn’t come to palliative care from arm’s length. It was her top pick. “Palliative care was my first choice in my RN graduate program, other staff were astonished, ‘you could have done theatre or ICU?’” “In the culture I…...
Lillian Brady receives McKnight Scholar Award
6+ hour, 31+ min ago (287+ words) Lillian Brady was selected to receive a 2026 McKnight Scholar Award from The McKnight Endowment Fund for Neuroscience. The award recognizes early-career scientists who are establishing independent research programs and advancing neuroscience. The McKnight Scholar Awards have supported innovative neuroscience investigators…...
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
6+ hour, 39+ min ago (499+ words) These results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, Republic of Korea (Abstract PL03.01). These data were also simultaneously published…...
Félix Guerrero-Ramos on Bladder Cancer Advances
1+ week, 2+ day ago (653+ words) EMJ This site is intended for healthcare professionals Félix Guerrero-Ramos on Bladder Cancer Advances Félix Guerrero-Ramos | Oncologic Urology Unit Coordinator, Department of Urology, Hospital Universitario 12 de Octubre, Madrid; Co-founder, Danae Urogenomics, Madrid, Spain What first drew you to uro-oncology and,…...